340 related articles for article (PubMed ID: 17333791)
1. [Knowledge about hepatitis B and C viruses and HIV among blood donors in Casablanca].
Boutayeb H; Aamoum A; Benchemsi N
East Mediterr Health J; 2006 Sep; 12(5):538-47. PubMed ID: 17333791
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence of HIV and hepatitis B and C among drug addicts in the city of Copenhagen].
Fuglsang T; Fouchard JR; Ege PP
Ugeskr Laeger; 2000 Jul; 162(27):3860-4. PubMed ID: 10920701
[TBL] [Abstract][Full Text] [Related]
3. Knowledge about hepatitis B and C among patients attending family medicine clinics in Karachi.
Khuwaja AK; Qureshi R; Fatmi Z
East Mediterr Health J; 2002 Nov; 8(6):787-93. PubMed ID: 15568456
[TBL] [Abstract][Full Text] [Related]
4. [Widespread risk behavior among injecting drug users. Over 80 percent HCV-infected--7 percent have HIV, as demonstrated by the first baseline study].
Hillgren K; Sarkar K; Elofsson S; Britton S
Lakartidningen; 2012 Jun 19-26; 109(25):1221-5. PubMed ID: 22838111
[No Abstract] [Full Text] [Related]
5. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
[TBL] [Abstract][Full Text] [Related]
6. Knowledge, attitudes and practices of barbers about hepatitis B and C transmission in Hyderabad, Pakistan.
Jokhio AH; Bhatti TA; Memon S
East Mediterr Health J; 2010 Oct; 16(10):1079-84. PubMed ID: 21222425
[TBL] [Abstract][Full Text] [Related]
7. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention.
Koester S; Glanz J; Barón A
AIDS Behav; 2005 Mar; 9(1):27-39. PubMed ID: 15812611
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran.
Imani R; Karimi A; Rouzbahani R; Rouzbahani A
East Mediterr Health J; 2008; 14(5):1136-41. PubMed ID: 19161086
[TBL] [Abstract][Full Text] [Related]
9. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
10. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
11. Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study.
Ruan Y; Qin G; Yin L; Chen K; Qian HZ; Hao C; Liang S; Zhu J; Xing H; Hong K; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S39-46. PubMed ID: 18172390
[TBL] [Abstract][Full Text] [Related]
12. [The influence of professional degree on the knowledge of HIV, HBV and HCV infections in dentistry practice].
Vitale F; Di Benedetto MA; Casuccio A; Firenze A; Calandra G; Ballarò F; Romano N
Ann Ig; 2005; 17(3):185-96. PubMed ID: 16041921
[TBL] [Abstract][Full Text] [Related]
13. Bloodborne and sexually transmitted infections in drug users in a hospital in Buenos Aires, Argentina.
Moscatello G; Campello P; Benetucci JA
Clin Infect Dis; 2003 Dec; 37 Suppl 5():S343-7. PubMed ID: 14648444
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors: a hospital based study.
Pahuja S; Sharma M; Baitha B; Jain M
Jpn J Infect Dis; 2007 Nov; 60(6):389-91. PubMed ID: 18032841
[TBL] [Abstract][Full Text] [Related]
15. Prisoners' knowledge of HIV/AIDS and its prevention in Kerman, Islamic Republic of Iran.
Nakhaee FH
East Mediterr Health J; 2002 Nov; 8(6):725-31. PubMed ID: 15568449
[TBL] [Abstract][Full Text] [Related]
16. Assessment of risky injection practices associated with hepatitis B, hepatitis C, and human immunodeficiency virus and using the blood-borne virus transmission risk assessment questionnaire.
Reynolds GL; Fisher DG; Napper LE
J Addict Dis; 2012; 31(1):80-8. PubMed ID: 22356671
[TBL] [Abstract][Full Text] [Related]
17. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
[TBL] [Abstract][Full Text] [Related]
18. Knowledge, attitude, and practice of Iranian surgeons about blood-borne diseases.
Moghimi M; Marashi SA; Kabir A; Taghipour HR; Faghihi-Kashani AH; Ghoddoosi I; Alavian SM
J Surg Res; 2009 Jan; 151(1):80-4. PubMed ID: 18599085
[TBL] [Abstract][Full Text] [Related]
19. Control of blood-transmitted infections in dentistry.
Neguţ EA; Bălteanu M; Ionescu G; Băncescu A; Iliescu A; Skaug N
Roum Arch Microbiol Immunol; 2007; 66(1-2):26-36. PubMed ID: 18928060
[TBL] [Abstract][Full Text] [Related]
20. Lessons from HIV and hepatitis viruses.
Sacks SL; Griffiths PD; Corey L; Cohen C; Cunningham A; Dusheiko GM; Self S; Spruance S; Stanberry LR; Wald A; Whitley RJ
Antiviral Res; 2004 Aug; 63 Suppl 1():S11-8. PubMed ID: 15450381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
